TGM2 and Cowden disease: The sensitivity for established CD (Biopsy‐based CD diagnosis, Anti‐TG2‐based CD diagnosis, and Marsh 3 histopathology and negative anti‐TG2) was 93%, and decreased when Potential CD with progression and Potential CD without progression were included (77%) (Table 3).